Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder
Start Date
2/19/2025
Completion Date
5/31/2027
Summary
The primary objective of this trial is to measure changes in physiologic signals to quantify the status of the autonomic nervous system during opioid withdrawal and cravings.
Detailed Description
This is a prospective observational clinical trial in which 20 participants with a history of dependence on prescription or non-prescription opioids will be recruited for collection of physiologic data via wearable sensors during a 14-day inpatient detoxification treatment. The EmbracePlus Smartwatch and Corti Sensor will be worn continuously throughout the 14-day treatment course to detect heart rate, heart rate variability, skin conductance, skin temperature, motion, and cortisol levels.
Eligibility Criteria
Age Range: 18 years to 50 years
Interventions
EmbracePlus Smartwatch
Corti Sensor
Conditions
Locations
Hazelden Betty Ford Foundation
Center City, Minnesota 55012
United States
Battelle Memorial Institute
Columbus, Ohio 43201
United States